Lyell Immunopharma (LYEL) EPS (Basic) (2020 - 2026)
Lyell Immunopharma (LYEL) posted EPS (Basic) of -$4.72 for Q1 2026, up 44.26% sequentially from -$8.47 in Q4 2025, and up 45.98% YoY from -$3.23 in Q1 2025.
Powered by 
Analysis
Lyell Immunopharma (LYEL) EPS (Basic) (2020 - 2026) Analysis & Trends
Lyell Immunopharma has reported EPS (Basic) for 7 years, with the latest figure at -$4.72 in Q1 2026.
- Quarterly EPS (Basic) rose 45.98% year-over-year to -$4.72 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.28 (up 66.73% YoY) and the FY2025 annual result came in at -$16.76, up 69.47% from the prior year.
- EPS (Basic) rose to -$4.72 in Q1 2026 per LYEL's latest filing, from -$8.47 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$1.1 in Q4 2022 and troughed at -$42.91 in Q4 2024.
- A 5-year average of -$11.12 and a median of -$8.47 in 2025 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) surged 100.0% in 2022, then sank 2127.98% in 2023.
- Over 5 years, EPS (Basic) stood at -$1.1 in 2022, then tumbled by 2127.98% to -$24.45 in 2023, then slumped by 75.51% to -$42.91 in 2024, then jumped by 80.27% to -$8.47 in 2025, then soared by 44.26% to -$4.72 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$4.72, -$8.47, and -$5.59 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Lyell Immunopharma | 335.97 Mn | 335.97 Mn | - | -1.93 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.93 |
| Mar 31, 2026 | -1.92 |
| Dec 31, 2025 | -7.31 |
| Sep 30, 2025 | -1.86 |
| Jun 30, 2025 | -2.97 |
| Mar 31, 2025 | -3.63 |
| Dec 31, 2024 | -15.01 |
| Sep 30, 2024 | -3.48 |
| Jun 30, 2024 | -3.54 |
| Mar 31, 2024 | -3.84 |
| Dec 31, 2023 | -4.18 |
| Sep 30, 2023 | -4.17 |
| Jun 30, 2023 | -4.85 |
| Mar 31, 2023 | -4.65 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | -5.17 |
| Jun 30, 2022 | -3.17 |
| Mar 31, 2022 | -6.02 |
| Dec 31, 2021 | -7.40 |
| Sep 30, 2021 | -4.08 |